IRD · Opus Genetics Inc
United States · RS rating 65 · As of 2026-11-03
| Price | 3.93 USD |
|---|---|
| 1-day change | +6.2% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 34 / 75 / 90 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 36 / 41 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +89.3% |
| Sales growth Q/Q | +25.5% |
| Distance from 52-week high | +35.3% |
| Market cap (USD) | $372.0M |